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CASE HISTORY
A man aged 31 was seen with a two-week history of progressive incoordination, lower limb weakness, right hemifacial tingling and paraesthesia in the hands. A similar episode had occurred 4 years previously with good recovery. On examination he had upper limb ataxia, a mild spastic paraparesis with a sensory level to D6 and bilateral extensor plantar responses. The results of routine investigations were normal apart from a slight increase in liver enzymes. Cerebrospinal¯uid (CSF) analysis was unremarkable, with absence of oligoclonal bands, but visual evoked potentials (VEPs) showed a delay in the P100 latency to pattern stimulation bilaterally (right eye 154 ms, left eye 150 ms) with amplitude preservation. Peripheral nerve conduction was normal.
The patient subsequently revealed that he had sniffed glue (Evostick, up to 5 L/week) since the age of 15 years; other recreational drugs, including alcohol, had not been used. Very high urinary hippuric acid levels (a marker of toluene exposure or intake) were consistent with inhalational abuse of toluene. Magnetic resonance imaging (MRI) of the brain showed diffuse high signal within the cerebral white matter on T2-weighted images (Figure 1 ). Spinal cord MRI was normal.
Solvents were withheld. After inpatient rehabilitation he became able to walk unaided with slight gait ataxia. Six months later he returned with an acute encephalopathy, increasing ataxia and distal dysaesthesia, having resumed glue-snif®ng. Cognitive function, ataxia and sensory symptoms recovered over 4 days with supportive management and detoxi®cation. He remained well for two months but subsequently experienced a deterioration in mobility with impaired visual acuity, facial numbness and urinary sphincter disturbance. Ataxia prevented him from walking. Two years after we ®rst saw him he relapsed again, with worsening mobility, diplopia and urinary incontinence. He was admitted for one week and solvents were again withheld. A month after discharge, diplopia, sphincter function and mobility had improved. At present he is independently mobile with a stick for occasional support.
COMMENT
Most volatile glues contain toluene and n-hexane. Toluene is believed to be the main cause of central nervous system damage 2 . Long-term solvent abuse can cause permanent neurological de®cits, and neuropathological studies of chronic users have revealed diffuse white matter demyelination and limited axonal degeneration. After short-term exposure to toluene-containing solvents, complete neurological recovery is usual.
If our patient had not been so candid about his recreational drug use an initial diagnosis of clinically de®nite MS could have been made. His features were not typical of solvent exposure. Often, chronic solvent abuse is characterized by an insidious, progressive, neurological course. In this case, the patient presented acutely despite 15 years of glue-snif®ng. He made a good recovery following each`relapse'. An acute neurological presentation of solvent abuse may therefore occur on a background of chronic exposure. Probably the relapses in this patient were associated with increased solvent abuse. The mechanism of relapse with rapid recovery is unclear. One possibility is conduction block due to an effect on membrane function and action potential transmission, with recovery as toluene and its metabolites are cleared.
Paraclinical tests such as VEPs, MRI, and CSF analysis are commonly used to support the diagnosis of MS but can be abnormal also in solvent-induced demyelination. Delay in VEP latency, reported in up to 95% of patients with MS, has been seen in paint-thinner abusers and in symptomless workers with chronic low-level exposure to toluene 3 . Might this patient have had MS, with the glue-snif®ng incidental? Diffuse white matter changes on MRI, as observed here, have previously been described in abusers of volatile glues 4 . By contrast, in MS diffuse white matter changes would be very unusual: up to 99% of patients with clinically de®nite MS have at least one focal white matter abnormality 5 . Absence of oligoclonal bands unique to the CSF, as noted in this case, has been reported in only 3% of patients with clinically de®nite MS 6 .
In patients with symptoms and a clinical course suggestive of MS, glue-snif®ng is a possible aetiology to be considered. Unusual clinical features such as encephalopathy during a relapse, and atypical features such as the presence of diffuse white matter lesions on MRI, will reinforce suspicion of a non-MS cause. In these cases particularly, a history of recreational and occupational exposure to toluene (dry cleaning, paint spraying, industrial cleaning) should be sought. When symptoms point to diabetes, the diagnosis can be con®rmed by a random blood glucose concentration greater than 11 mmol/L, usually with concurrent glycosuria 1 . Sometimes the result is misleading.
Alimentary hyperglycaemia mistaken for diabetes mellitus

CASE HISTORY
A man aged 76 attended a diabetic clinic for 4 years for control of his diabetes, which responded well to diet alone. His HbA1c levels over this period were in the range 6.2± 7.5% (non-diabetic 56.1%). One of us (NAM) noticed that the diagnosis was initially based on a random serum glucose level of 13 mmol/L and the patient had not experienced typical symptoms of diabetes mellitus. An oral glucose tolerance test (GTT) showed a fasting plasma glucose of 5.2 and a 120-minute value of 2.8 mmol/L.
A prolonged GTT was arranged. The patient was advised to eat normally for at least 3 days before the test and to fast from 10 o'clock the night before the test. The glucose load was 130 mL Polycal (Nutricia) in 300 mL water, which was equivalent to 75 g glucose. The resulting glucose curve and urine sugar values are shown in Figure 1 . Fasting plasma glucose was normal at 4.6 mmol/L and the value rose to a peak of 15.4 mmol/L at 45 min and was normal at 120 min. The lowest plasma glucose was
